Critical Contrast: Balchem (NASDAQ:BCPC) vs. BioLargo (NASDAQ:BLGO)

BioLargo (NASDAQ:BLGO) and Balchem (NASDAQ:BCPC) are both construction companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation.

Volatility & Risk

BioLargo has a beta of 0.18, indicating that its stock price is 82% less volatile than the S&P 500. Comparatively, Balchem has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500.

Institutional & Insider Ownership

0.0% of BioLargo shares are owned by institutional investors. Comparatively, 87.9% of Balchem shares are owned by institutional investors. 20.3% of BioLargo shares are owned by company insiders. Comparatively, 1.3% of Balchem shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares BioLargo and Balchem’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioLargo	-16.53%	-58.35%	-32.12%
Balchem	12.52%	10.94%	7.34%

Analyst Ratings

This is a breakdown of current recommendations and price targets for BioLargo and Balchem, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLargo	0	0	0	0	N/A
Balchem	0	0	1	0	3.00

Balchem has a consensus target price of $185.00, indicating a potential upside of 7.43%. Given Balchem’s higher possible upside, analysts clearly believe Balchem is more favorable than BioLargo.

Earnings and Valuation

This table compares BioLargo and Balchem”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLargo	$12.23 million	5.88	-$3.50 million	($0.03)	-8.06
Balchem	$932.39 million	5.99	$108.54 million	$3.54	48.65

Balchem has higher revenue and earnings than BioLargo. BioLargo is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks.

Summary

Balchem beats BioLargo on 12 of the 13 factors compared between the two stocks.

About BioLargo

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per – and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.